Claim 50% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Zylox-Tonbridge Medical Technology Co., Ltd. Class H ( (HK:2190) ) has provided an announcement.
Zylox-Tonbridge Medical Technology has agreed to acquire a 49% equity stake in an independent medical technology firm, referred to as the Target Company, from E-Med Solutions for approximately EUR18.375 million (about RMB149.41 million), with the price subject to adjustment. The deal, completed under a sale and purchase agreement signed on 16 January 2026, also grants Zylox-Tonbridge an option to purchase the remaining shares in the Target Company from other shareholders at its discretion. The Target Company will not become a subsidiary after this transaction and its results will not be consolidated into Zylox-Tonbridge’s financial statements. Under Hong Kong listing rules, the acquisition is classified as a discloseable transaction requiring reporting and announcement but not shareholder approval, while the grant of the option involves no premium and therefore does not itself constitute a notifiable transaction, signaling a measured expansion strategy that preserves financial flexibility and regulatory compliance.
The most recent analyst rating on (HK:2190) stock is a Hold with a HK$24.50 price target. To see the full list of analyst forecasts on Zylox-Tonbridge Medical Technology Co., Ltd. Class H stock, see the HK:2190 Stock Forecast page.
More about Zylox-Tonbridge Medical Technology Co., Ltd. Class H
Zylox-Tonbridge Medical Technology Co., Ltd. is a Hong Kong-listed medical technology company focused on developing and commercializing medical devices, with its shares traded under stock code 2190. The company operates in the healthcare sector, pursuing strategic investments and partnerships to broaden its product portfolio and strengthen its position in global medical technology markets.
Average Trading Volume: 728,422
Technical Sentiment Signal: Buy
Current Market Cap: HK$8.88B
See more data about 2190 stock on TipRanks’ Stock Analysis page.